Opinion Filling the gap in mental health research Ways to tackle the lack of funding in mental health research.…Published: 12 November 2015
Opinion A useful reference text of psychotropic medicines ‘Clinical handbook of psychotropic drugs 21st edition’, edited by Ric M Procyshyn, Kalyna Z Bezchlibnyk-Butler, J Joel Jeffries.…Published: 30 October 2015
News Antipsychotic drug aripiprazole could aid antidepressant therapies in older adults Elderly patients with depression who are not helped by a first-line antidepressant could benefit from the addition of an antipsychotic drug, finds a study published in The Lancet.…Published: 5 October 2015
News ‘Digital pill’ assessed for approval by FDA A drug embedded with a digital sensor that records when a patient’s stomach is ingesting the medicine is being assessed for approval by the US medicines safety watchdog.…Published: 25 September 2015
News FDA gives the green light for cariprazine to treat schizophrenia or bipolar disorder The US Food and Drug Administration has approved the atypical antipsychotic cariprazine (Vraylar) to treat adults with schizophrenia or bipolar disorder.…Published: 24 September 2015
Opinion How we are trying to make hospital visits better for patients with learning disabilitiesFourth-year pharmacy student Ibrahim Abbadi, who completed a summer placement at Chelsea and Westminster Hospital, explains what the hospital is doing to improve care for patients with learning disabilities.…Published: 23 September 2015
News Association between SSRI use and violent crime could be explained by poor adherence An association between the use of a class of antidepressant known as selective serotonin reuptake inhibitors and violent crime in patients aged 15–24 years has been found by researchers.…Published: 21 September 2015
News How mental health is being improved by community pharmacists in Canada Community pharmacists in Canada are delivering a new type of mental health service called the Bloom Program.…Published: 18 September 2015
News Analysis of paroxetine trial sparks debate over access to trial data An analysis of a controversial yet influential study into the use of paroxetine in adolescents has reignited the debate over full disclosure of clinical trial data.…Published: 18 September 2015
Feature Placebos: more than meets the eye Often dismissed as fakes, placebos seem to work on the same brain pathways targeted by ‘real’ treatments and involve a complex network of genes.…Published: 17 September 2015